Clinical Trials Browser

Phase 3 × Has results × Febrile Neutropenia × Clear all

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Phase 3 Completed

847 enrolled 21 charts

Classical hematologyGastrointestinal

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

Phase 3 Completed

135 enrolled 18 charts

BreastClassical hematology

Breast Neoplasms, Neutropenia, Febrile Neutropenia